Hjem › Wilms tumor › Massachusetts
Wilms tumor kliniske forsøg i Massachusetts
4 studier for Wilms tumor søger deltagere på steder i Massachusetts.
Byer i Massachusetts
Officiel studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 29. sep. 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Dana-Farber Cancer Institute, Boston
- UMass Memorial Medical Center - University Campus, Worcester
RekruttererFase 2
Op til 30 år · Alle køn · Opdateret 25. aug. 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Dana Farber Cancer Institute (Data Collection Only), Boston
RekruttererFase 2
12 Months · Alle køn · Opdateret 6. maj 2026 · NCT05985161Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.